Lieselotte Veryser is Senior CMC Writer at Ardena Ghent. She holds a PhD in Pharmaceutical Sciences and has been part of the CMC Regulatory team since 2016.
Throughout her career at Ardena, Lieselotte has developed extensive expertise in supporting drug product programs from early development through market readiness. She focuses on the authoring and review of CMC documentation using a dossier-centric approach aligned with regulatory requirements in GMP-regulated environments. Her expertise includes pharmaceutical development, technology transfer, and regulatory documentation supporting high-quality drug product development programs.
Lieselotte combines scientific expertise with strong regulatory knowledge to support robust and compliant pharmaceutical development activities.
